Market Place
Sourcing Support
Innovent`s Weight-Loss Drug Highlights China Challenge for Novo
22 Sep 2025 //
REUTERS
Ascletis Reveal ASC47 with Semaglutide, 56.2% More Weight Loss
21 Sep 2025 //
PR NEWSWIRE
Indian API Makers Gear Up for Semaglutide Demand
20 Sep 2025 //
PRESS RELEASE
Europe`s CHMP Approves Novo`s Kyinsu, Bayer`s Lynkuet
19 Sep 2025 //
FIERCE PHARMA
Novo Boosts Wegovy Pill Case Before FDA Decision
18 Sep 2025 //
FIERCE PHARMA
Serena Williams Promotes GLP-1s for Ro Amid Pharma Oversight
17 Sep 2025 //
BIOSPACE
Indian Pharma Giants Dr Reddy`s and Macleods Gear Up for Ozempic
17 Sep 2025 //
ECONOMICTIMES
Novo Says Wegovy Pill Shows Comparable Weight-Loss to Injectable
17 Sep 2025 //
REUTERS
EU Approves Novo`s Oral Semaglutide, Reduce Cardiovascular Death
15 Sep 2025 //
GLOBENEWSWIRE
Novo’s Wegovy Cuts Food Noise, Lifts Mental Well-Being
15 Sep 2025 //
GLOBENEWSWIRE
BioNxt Advances Semaglutide ODF Program with Prototype
15 Sep 2025 //
ACCESSWIRE
WHO Adds Popular Weight-Loss Drugs to Essential Medicines List
11 Sep 2025 //
ECONOMICTIMES
Wegovy-Maker Novo to Slash 9,000 Jobs as Competition Heats Up
10 Sep 2025 //
REUTERS
Enforcement Report - Week of September 10, 2025
10 Sep 2025 //
FDA
Novo, Lilly Obesity Drugs Deemed `Highly Cost-Effective` by ICER
09 Sep 2025 //
FIERCE PHARMA
WHO Includes GLP-1s in Essential Medicines List
08 Sep 2025 //
BIOSPACE
Europe Warns of Surge in Illegal Obesity Drugs
05 Sep 2025 //
FIERCE PHARMA
Novo Nordisk to Unveil Semaglutide Data on `Food Noise`
05 Sep 2025 //
GLOBENEWSWIRE
Vivani Update on NPM-139 Semaglutide Implant in weight Management
04 Sep 2025 //
GLOBENEWSWIRE
Skye Completes 26-week Treatment Phase in Phase 2a CBeyond™ Study
02 Sep 2025 //
GLOBENEWSWIRE
BioNxt Begins Lab-Scale ODF Development with Semaglutide API
02 Sep 2025 //
ACCESSWIRE
Novo’s Wegovy Cuts Risk of Heart Attack or Death by 57%
31 Aug 2025 //
GLOBENEWSWIRE
Novo`s Wegovy Cuts Heart Risk by 57% versus Rival Lilly Drug
30 Aug 2025 //
REUTERS
Cheaper Obesity Drugs: Cure or Crisis for India?
25 Aug 2025 //
PRESS RELEASE
IMA Cautions Against Misuse of Weight-Loss Drugs Wegovy, Mounjaro
23 Aug 2025 //
ECONOMICTIMES
CDSCO issues Alert on Novo Drugs After Reported Theft
22 Aug 2025 //
ECONOMICTIMES
Parker Waichman Files Suit for Ozempic-Linked NAION Vision Loss
20 Aug 2025 //
PR NEWSWIRE
Novo to Showcase Wegovy & Ozempic Benefits at ESC Congress 2025
20 Aug 2025 //
GLOBENEWSWIRE
Canada Approves Ozempic to Cut Risk of Kidney Failure
20 Aug 2025 //
REUTERS
Novo Nordisk Unveils $499 Cash-Pay Ozempic Offering
19 Aug 2025 //
FIERCE PHARMA
Novo Nordisk cuts Ozempic® price to $499/month for self-paying
18 Aug 2025 //
PR NEWSWIRE
Novo`s Wegovy Gets Accelerated Approval for Liver Disease MASH
18 Aug 2025 //
REUTERS
Enforcement Report - Week of August 13, 2025
13 Aug 2025 //
FDA
Ascletis ASC47 Shows Higher Efficacy With Tirzepatide In Obesity
12 Aug 2025 //
PR NEWSWIRE
Novo Nordisk`s Wegovy, Mounjaro sales double in India in July
07 Aug 2025 //
ECONOMICTIMES
Novo Nordisk Broadens Legal Action to Safeguard Us Patients
06 Aug 2025 //
PR NEWSWIRE
Novo Nordisk Sues Over 14 Unapproved Semaglutide Drugs in New
06 Aug 2025 //
INDPHARMAPOST
Wegovy maker Novo Nordisk to Reduce Costs After $95 billion stock
06 Aug 2025 //
REUTERS
Eris Lifesciences Eyes ‘good’ Share in Semaglutide Generics
05 Aug 2025 //
ECONOMICTIMES
Obesity Drug Trials Underway in Big and Small Pharma Labs
31 Jul 2025 //
ECONOMICTIMES
FuturHealth to Distribute Affordable FDA-Approved GLP-1s
30 Jul 2025 //
PR NEWSWIRE
Torrent Pharmaceuticals to Launch Semaglutide After Patent Expiry
29 Jul 2025 //
ECONOMICTIMES
Ascletis Starts US Ph2a Study for Obesity Drug ASC30
28 Jul 2025 //
PR NEWSWIRE
Dr Reddy`s Plan to Launch Generic of Novo`s Weight-Loss Drug
24 Jul 2025 //
REUTERS
Biocon Aims to Launch Generic Wegovy in India by 2027, Says CEO
16 Jul 2025 //
ECONOMICTIMES
ET Graphics: Tirzepatide, Semaglutide lead India, misuse concerns
16 Jul 2025 //
ECONOMICTIMES
Ascletis Completes ASC47 + Semaglutide Dosing in U.S. Study
14 Jul 2025 //
PR NEWSWIRE
Novo Nordisk seeks EMA Approval For higher Wegovy Dose in Obesity
09 Jul 2025 //
INDPHARMAPOST
Remote Pharmacy updates availability of GLP-1 weight loss
03 Jul 2025 //
GLOBENEWSWIRE
GLP-1 Patent Expiry 2026: A Defining Opportunity for Indian Pharm
02 Jul 2025 //
PRESS RELEASE
WeightWatchers, Novo Nordisk Expand Collaboration for Medication
01 Jul 2025 //
GLOBENEWSWIRE
Novo Nordisk Supports Patient Access to Wegovy and Safety
26 Jun 2025 //
PR NEWSWIRE
Novo Nordisk launches weight-loss drug Wegovy in India
25 Jun 2025 //
REUTERS
EMA to Allow Novo to Include Heart Condition in Ozempic Label
24 Jun 2025 //
REUTERS
Judge backs FDA`s Removal of Ozempic, Wegovy from Shortage list
18 Jun 2025 //
REUTERS
AI GLP-1 Peptides From IPA Surpass Semaglutide in Studies
12 Jun 2025 //
BUSINESSWIRE
Novo Nordisk starts new CagriSema weightloss drug trial
11 Jun 2025 //
REUTERS
ADA 2025: Novo Nordisk showcases new semaglutide data, redefining
10 Jun 2025 //
GLOBENEWSWIRE
Novo`s Ozempic Linked to Rare Cases of Serious Eye Disorder
09 Jun 2025 //
REUTERS
Exclusive: Wegovy use up 50% among US teens
03 Jun 2025 //
REUTERS
